Company Analysis

Humacyte, Inc. (HUMA)

Nasdaq: HUMA · Biological Products, (No Diagnostic Substances) · Durham, NC · filing with the SEC since 2020
Grade3.9
◀ Past 4.2● Present 3.2▶ Future 4.3
4 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

14 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Humacyte, Inc.’s names, not what it holds today.

Patents granted
14
14 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 2 in 2024 and none in 2023
Applications published
21
2 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'09'11'12'13'14'15'17'18'19'20'21'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Medical technology4
Biotechnology3
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Humacyte, Inc its own name
US, as the owner printed on each patent
14 granted
11 published
Humacyte, Inc. its own name
named as the applicant on its applications, in US
0 granted
10 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Nov 18, 202512,472,057Tubular prosthesesMedical technologyHumacyte, Inc
Jan 14, 202512,195,711Drawer system for cultivating tissueBiotechnologyHumacyte, Inc
Oct 1, 202412,104,148System, apparatuses, devices and methods for straining a cultivated tissueBiotechnologyHumacyte, Inc
Apr 16, 202411,959,060Fluid systems, apparatuses, devices and methods of management thereof for cultivating tissueBiotechnologyHumacyte, Inc
Jul 13, 202111,058,534Tubular prosthesesMedical technologyHumacyte, Inc
Mar 16, 202110,947,498Tissue-engineered constructsMedical technologyHumacyte, Inc
Mar 2, 202110,934,522Tissue-engineered constructsMedical technologyHumacyte, Inc
Apr 14, 202010,619,132Tissue-engineered constructsMedical technologyHumacyte, Inc
Jul 30, 201910,363,124Methods and apparatuses for forming fibrous tubesOther special machinesHumacyte, Inc
Jan 8, 201910,172,707Tubular prosthesesMedical technologyHumacyte, Inc
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
May 29, 20252025/0171734TISSUE-ENGINEERED CONSTRUCTSMedical technologyHumacyte, Inc.
May 1, 20252025/0135069APPARATUS AND METHODS OF A TUBULAR TISSUE AS A THERAPEUTIC AGENT-PRODUCING SHEATH FOR A VASCULAR GRAFTMedical technologyHumacyte, Inc.
Jan 26, 20232023/0026520SYSTEMS, DEVICES AND METHODS FOR ENGINEERED TISSUE CONSTRUCT TRANSPORT AND CONTAINMENTBiotechnologyHumacyte, Inc.
Aug 12, 20212021/0246419TISSUE-ENGINEERED CONSTRUCTSMedical technologyHumacyte, Inc
Aug 5, 20212021/0236273Tubular ProsthesesMedical technologyHumacyte, Inc · patent 12,472,057 granted from it
Mar 7, 20192019/0069990Tubular ProsthesesMedical technologyHumacyte, Inc · patent 11,058,534 granted from it
Oct 11, 20182018/0291333TISSUE-ENGINEERED CONSTRUCTSMedical technologyHumacyte, Inc · patent 10,947,498 granted from it
Sep 6, 20182018/0251727TISSUE-ENGINEERED CONSTRUCTSMedical technologyHumacyte, Inc · patent 10,934,522 granted from it
Oct 26, 20172017/0306292TISSUE-ENGINEERED CONSTRUCTSMedical technologyHumacyte, Inc. · patent 10,619,132 granted from it
Oct 19, 20172017/0296323METHODS AND APPARATUSES FOR FORMING FIBROUS TUBESOther special machinesHumacyte, Inc · patent 10,363,124 granted from it
What it applied for, 2024 to 2025: Medical technology 2.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton HUMA · research, not advice